Open AccessTowards 2030 target for hepatitis B and C viruses elimination: Assessing the validity of predonation rapid diagnostic tests versus enzyme-linked immunosorbent assay in state hospitals in Kaduna, Nigeria
Author(s) -
Ismaila Nda Ibrahim,
Aisha Indo Mamman,
Muhammad Shakir Balogun,
Aliyu Babadoko,
Abdulaziz Hassan,
Benjamin Augustine,
Abubakar Suleiman,
Ibrahim Usman Kusfa
Publication year - 2019
Publication title -
nigerian medical journal/nigerian medical journal
Language(s) - English
Resource type - Journals
eISSN - 2229-774X
pISSN - 0300-1652
DOI - 10.4103/nmj.nmj_93_18
Subject(s) - medicine , hbsag , hepatitis c virus , antibody , hepatitis b , virology , hepatitis b virus , economic shortage , immunology , hepatitis c , blood transfusion , virus , linguistics , philosophy , government (linguistics)
Sub-Saharan Africa accounts for 25% of the estimated global 325 million people with chronic hepatitis B and C virus infections. Weak blood transfusion systems facilitate the spread of both hepatitis B and C virus infections. This is worsened by the absence of sustainable quality assurance programs and perennial shortage of sensitive screening kits. We aim to compare the validity of rapid diagnostic tests (RDTs) with the World Health Organization-recommended quality-assured enzyme-linked immunosorbent assay (ELISA) screening method for these viruses.